By Maddie Sorenson
TheStreet downgraded shares of Integra Lifesciences Holdings Corp (NASDAQ
:IART) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning, MarketBeat reports.
Shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) opened at 63.20 on Tuesday. The stock has a 50 day moving average of $60.48 and a 200 day moving average of $60.97. Integra Lifesciences Holdings Corp has a 12-month low of $42.09 and a 12-month high of $68.46. The company’s market cap is $2.10 billion. 
Integra Lifesciences Holdings Corp (NASDAQ:IART) last issued its quarterly earnings resultson Tuesday, November 3rd. The company reported $0.75 EPS for the quarter, topping the consensus estimate of $0.74 by $0.01. During the same period in the previous year, the firm posted $0.71 EPS. The company earned $226.40 million during the quarter, compared to analysts’ expectations of $224.08 million. Integra Lifesciences Holdings Corp’s revenue was up 14.6% compared to the same quarter last year. Equities research analysts predict that Integra Lifesciences Holdings Corp will post $3.07 earnings per share for the current fiscal year.